YTHDF1 and melanoma: IHC results for YTHDF1 from 31 MCC patients revealed this protein to be expressed at high levels in 23/31 (74.2%) of samples while only 1/26 (3.8%) of melanoma patients expressed YTHDF1 at high levels.